<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(4)</volume><submitter>Witt A</submitter><pubmed_abstract>XIAP is a caspase-inhibitory protein that blocks several cell death pathways, and mediates proper activation of inflammatory NOD2-RIP2 signaling. XIAP deficiency in patients with inflammatory diseases such as Crohn's disease, or those needing allogeneic hematopoietic cell transplantation, is associated with a worse prognosis. In this study, we show that XIAP absence sensitizes cells and mice to LPS- and TNF-mediated cell death without affecting LPS- or TNF-induced NF-κB and MAPK signaling. In XIAP deficient mice, RIP1 inhibition effectively blocks TNF-stimulated cell death, hypothermia, lethality, cytokine/chemokine release, intestinal tissue damage and granulocyte migration. By contrast, inhibition of the related kinase RIP2 does not affect TNF-stimulated events, suggesting a lack of invo</pubmed_abstract><journal>Cell death &amp; disease</journal><pagination>262</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10090100</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>XIAP deletion sensitizes mice to TNF-induced and RIP1-mediated death.</pubmed_title><pmcid>PMC10090100</pmcid><pubmed_authors>Witt A</pubmed_authors><pubmed_authors>Vucic D</pubmed_authors><pubmed_authors>Webster JD</pubmed_authors><pubmed_authors>Kist M</pubmed_authors><pubmed_authors>Dugger D</pubmed_authors><pubmed_authors>Lee YM</pubmed_authors><pubmed_authors>Newton K</pubmed_authors><pubmed_authors>Eastham J</pubmed_authors><pubmed_authors>Dohse M</pubmed_authors><pubmed_authors>Goncharov T</pubmed_authors></additional><is_claimable>false</is_claimable><name>XIAP deletion sensitizes mice to TNF-induced and RIP1-mediated death.</name><description>XIAP is a caspase-inhibitory protein that blocks several cell death pathways, and mediates proper activation of inflammatory NOD2-RIP2 signaling. XIAP deficiency in patients with inflammatory diseases such as Crohn's disease, or those needing allogeneic hematopoietic cell transplantation, is associated with a worse prognosis. In this study, we show that XIAP absence sensitizes cells and mice to LPS- and TNF-mediated cell death without affecting LPS- or TNF-induced NF-κB and MAPK signaling. In XIAP deficient mice, RIP1 inhibition effectively blocks TNF-stimulated cell death, hypothermia, lethality, cytokine/chemokine release, intestinal tissue damage and granulocyte migration. By contrast, inhibition of the related kinase RIP2 does not affect TNF-stimulated events, suggesting a lack of invo</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2025-04-04T12:01:38.267Z</modification><creation>2025-04-04T12:01:38.267Z</creation></dates><accession>S-EPMC10090100</accession><cross_references><pubmed>37041175</pubmed><doi>10.1038/s41419-023-05793-1</doi></cross_references></HashMap>